FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902 million which beat the analyst consensus estimate of $36.666 million by 52.46% and is a significant increase over sales of $36.161 million from the same period last year.
Beyond reported quarterly losses of $1.22 per share which missed the analyst consensus estimate of losses of 87 cents by 40.23%. Quarterly sales came in at $382.281 million which missed the analyst consensus estimate of $389.264 million by 1.79%.
Jumia Technologies shares are trading higher Tuesday after the company reported strong first-quarter revenue results. The company reported first-quarter revenue of $49 million, up 19% year-over-year, and gross merchandise value of $181 million, up 5% year-over-year.
Builders FirstSource sees shares plummet over 17%. Despite Q1 earnings beat, company sees flat sales and decreased profit margins that disappoint investors.
Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essential Health segments. Kenvue's strategic workforce reduction and targeted cost savings.